|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1994-7-7
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the utility of positron emission tomography- (PET) 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) imaging in extracranial head and neck cancers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3047-58
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8200003-Adult,
pubmed-meshheading:8200003-Aged,
pubmed-meshheading:8200003-Deoxyglucose,
pubmed-meshheading:8200003-Female,
pubmed-meshheading:8200003-Fluorodeoxyglucose F18,
pubmed-meshheading:8200003-Head and Neck Neoplasms,
pubmed-meshheading:8200003-Humans,
pubmed-meshheading:8200003-Magnetic Resonance Imaging,
pubmed-meshheading:8200003-Male,
pubmed-meshheading:8200003-Middle Aged,
pubmed-meshheading:8200003-Neoplasm Recurrence, Local,
pubmed-meshheading:8200003-Neoplasm Staging,
pubmed-meshheading:8200003-Tomography, Emission-Computed
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers.
|
|
pubmed:affiliation |
Department of Molecular and Medical Pharmacology, UCLA School of Medicine.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|
